Luxbright
Luxbright AB is a Swedish technology company based in Gothenburg that develops and manufactures X-ray tubes for industrial applications. The company also supplies X-ray sources through partners and provides customer-specific solutions for non-destructive testing (NDT) uses, with operations centered in Sweden and a global customer reach.
Fiscal year 2025 · change from previous year
Development 2019–2025
Business
Share of revenueStandard and specialized X-ray tubes used in industrial inspection and NDT applications.
X-ray source offerings delivered in collaboration with external partners for specific customer needs.
Tailored X-ray and tube solutions designed around customer requirements and technical specifications.
NRE and prototype development for new tube models and application-specific programs.
Customers
Luxbright sells to industrial customers that need X-ray technology for inspection, testing and verification rather than medical imaging. Its customer base includes NDT users, industrial equipment buyers and partners that integrate the company’s tubes or sources into broader systems. The business also serves customers that require custom engineering, prototype development or application-specific performance characteristics.
Buy X-ray tubes and sources for non-destructive testing, inspection and verification.
Integrate Luxbright tubes or sources into industrial inspection systems and platforms.
Buy through collaboration structures where Luxbright supplies X-ray source technology.
Commission application-specific solutions, prototypes and NRE work for specialized needs.
Strategy
Luxbright’s strategy is to move from a development-focused company toward a commercial industrial supplier with broader product coverage. The company is expanding its tube portfolio, improving production stability and scalability, and using international partnerships to reach larger end markets. It also appears to be building optionality across both civilian industrial applications and defense-related opportunities.
Higher output and process stability are needed to convert technical capability into repeatable commercial supply.
New tube models can widen the addressable market and support volume growth.
Partner-led commercialization can accelerate market access in industrial X-ray applications.
Geography
Luxbright is headquartered in Gothenburg, Sweden, and its development, production and verification activities are carried out in Sweden. The company serves a global industrial market and has highlighted international collaboration, including with a U.S.-based partner, while also maintaining a presence in China through Suzhou Luxbright International Trade Co. Ltd. Geography matters because the business combines Swedish manufacturing control with export-oriented customer demand and partner relationships abroad.
Risks
Luxbright’s main risks come from its early-stage commercialization, dependence on successful product development and the need to fund ongoing operations. As a niche industrial technology supplier, it also faces execution risk in manufacturing scale-up, customer concentration risk in partner-led programs and the usual demand cyclicality of industrial capital equipment markets.
- Going-concern and financing riskImpact: Critical
The company states it needs financing for continued operations, making capital access critical.
Exposure: Corporate funding and working capital
- Manufacturing scale-up riskImpact: HighLikelihood: Low
Specialized X-ray tube production requires stable processes, quality control and yield improvement.
Exposure: Production and delivery execution
- Customer concentration and partner dependenceImpact: High
A meaningful part of commercialization appears tied to a small number of strategic relationships.
Exposure: Fisica collaboration and other partner-led programs
- Product development riskImpact: MediumLikelihood: Low
New tube models and NRE programs may not convert into repeatable volume sales.
Exposure: Prototype and custom development
Accounting
Judgemental itemsThe company reports both standard product sales and customer-financed development, which may be recognized differently.
Impact: Affects timing and comparability of quarterly revenue
The business relies on technical development, so capitalization and impairment judgments can materially affect assets and earnings.
Impact: Can change reported asset base and future amortization
Share issues and warrants are important funding tools for a growth-stage company.
Impact: Affects share count, equity and per-share metrics
Similar listed companies
Publicly listed companies with a comparable business focus.
Xeriant, Inc.
XERI · Aircraft
RxSight, Inc.
RXST · Ophthalmic Goods
Xbrane Biopharma
XBRANE · Health Care
Xbrane Biopharma AB is a biotechnology company specializing in the development of biosimilars, which are follow-up drugs introduced at a lower price after the original drug's patent expires.
Nuburu, Inc.
BURUW · Miscellaneous Electrical Machinery, Equipment & Supplies
Profoto Holding
PRFO · Consumer Discretionary
Profoto Holding AB is a Swedish company specializing in lighting equipment for professional photographers.
Varex Imaging Corp
VREX · Electronic Components, NEC
Varex Imaging Corp designs and manufactures X-ray imaging components and related systems used inside medical, security, and industrial inspection equipment.
Last updated: 24/09/2026